Results
|
1.
|
|
|
2.
|
Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study. MedStar authors:
Citation: - Diabetes Care. 36(4):992-7, 2013 Apr.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Capaldo B, de Simone G, Devereux RB, Di Bonito P, Howard BV, Iaccarino M, Lee ET, Riccardi G, Roman MJ
|
|
3.
|
Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study. MedStar authors:
- Calhoun, Darren
- Howard, Barbara V
- Shara, Nawar M
- Umans, Jason G
- Wang, Hong
Year: 2011
Citation: - Diabetes Care. 34(9):1952-8, 2011 Sep.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Calhoun D, de Simone G, Devereux R, Howard BV, Lee ET, Shara NM, Umans JG, Wang H
|
|
4.
|
Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. MedStar authors:
- Aroda, Vanita R
- Fernandez, Stephen J
- Ratner, Robert E
Year: 2013
Citation: - Diabetes Technology & Therapeutics. 15(2):117-23, 2013 Feb.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Aroda VR, Conway BN, Fernandez SJ, Matter NI, Maynard JD, Orchard TJ, Ratner RE
|
|
5.
|
Sex differences in obesity prevalence and cardiometabolic factors among Western Alaska Native people. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2015
Citation: - Nutrition Metabolism & Cardiovascular Diseases. 25(3):312-8, 2015 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, American Recovery and Reinvestment Act
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Austin MA, Boyer BB, Hopkins SE, Howard BV, Kaufmann C, Koller KR, Metzger JS, Umans JG, Wolfe AW
|
|
6.
|
|
|
7.
|
Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(10):2738-45, 2014 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Observational Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Aroda VR, Bray GA, Delahanty LM, Diabetes Prevention Program Research Group, Florez JC, Franks PW, Jablonski KA, Kahn SE, Pan Q, Perreault L, Watson KE
|
|
8.
|
Metabolic Profiles of Obesity in American Indians: The Strong Heart Family Study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2016
Citation: - PLoS ONE [Electronic Resource]. 11(7):e0159548, 2016
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Best LG, Howard BV, Jones DP, Lee ET, Tran VT, Umans JG, Uppal K, Zhao J, Zhao Q, Zhu Y
|
|
9.
|
|
|
10.
|
|
|
11.
|
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
|
|
12.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(9):1579-86, 2016 Sep
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
|
|
13.
|
|
|
14.
|
Toward Precision Medicine: TBC1D4 Disruption Is Common Among the Inuit and Leads to Underdiagnosis of Type 2 Diabetes. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(11):1889-1895, 2016 Nov
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Brassard P, Cole S, Comuzzie AG, Greenwood CM, Haack K, Kent JW Jr, Manousaki D, Newman DE, Richards JB, Rouleau G, Umans JG, Xie P, Zhou S
|
|
15.
|
Psychological trauma symptoms and Type 2 diabetes prevalence, glucose control, and treatment modality among American Indians in the Strong Heart Family Study. MedStar authors:
- Calhoun, Darren
- Howard, Barbara V
Year: 2013
Citation: - Journal of Diabetes & its Complications. 27(6):553-7, 2013 Nov-Dec.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Beals J, Calhoun D, Goldberg J, Gonzales KL, Howard BV, Jacob MM, Muller CJ, Nelson L, Welty TK
|
|
16.
|
|
|
17.
|
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
|
|
18.
|
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors:
Year: 2016
Citation: - Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J
|
|
19.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
|
|
20.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
21.
|
Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(9):2622-31, 2014 Sep.
All authors: - Diabetes Prevention Program Research Group, Goldberg RB, Hamman RF, Horton E, Kitabchi A, Larkin M, Mather KJ, Montez MG, Orchard TJ, Perreault L, Temprosa M, Thayer D
|
|
22.
|
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
- Fatemi, Omid
- Yuriditsky, Eugene
Citation: - American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
|
|
23.
|
|
|
24.
|
Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?. MedStar authors:
- Mete, Mihriye
- Zeymo, Alexander
Year: 2020
Citation: - Journal of Diabetes & its Complications. 34(4):107513, 2020 04.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Anhalt H, Flokas ME, Gourgari E, Mete M, Rother KI, Zeymo A
|
|
25.
|
THE SYNERGY TO ENABLE GLYCEMIC CONTROL FOLLOWING EMERGENCY DEPARTMENT DISCHARGE PROGRAM FOR ADULTS WITH TYPE 2 DIABETES: STEP-DIABETES. MedStar authors:
- Dubin, Jeffrey S
- Magee, Michelle
- Mete, Mihriye
- Nassar, Carine M
- White, Keyoana
- Youssef, Gretchen A
Year: 2015
Citation: - Endocrine Practice. 21(11):1227-39, 2015 Nov.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Emergency Medicine
- Medicine/Endocrinology
- MedStar Diabetes Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Dubin JS, Magee MF, Mete M, Nassar CM, White K, Youssef GA
|
|
26.
|
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
Year: 2018
Citation: - Diabetes Care. 41(2):258-266, 2018 02.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
|
|
27.
|
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
Year: 2020
Citation: - Diabetes Care. 43(5):940-947, 2020 05.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
|
|
28.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
|
29.
|
Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study. MedStar authors:
Year: 2017
Citation: - Cardiovascular Diabetology. 16(1):64, 2017 05 12
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Best LG, de Simone G, Devereux RB, Howard BV, Izzo R, Lee ET, Mancusi C, Roman MJ, Wang W, Yeh F
|
|
30.
|
Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes. MedStar authors:
- Baker, Kelley M
- Evans, Stephen R
- Fernandez, Stephen J
- Huang, Chun-Chi
- Magee, Michelle
- Mete, Mihriye
- Montero, Alex R
- Nassar, Carine M
- Sack, Paul A
- Smith, Kelly
- Youssef, Gretchen A
Year: 2019
Citation: - BMJ Open Diabetes Research & Care. 7(1):e000731, 2019.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Institute for Quality and Safety
- MedStar Union Memorial Hospital
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- MedStar Diabetes Institute
- MedStar Health, Columbia
Medline publication type:
All authors: - Baker KM, Evans SR, Fernandez SJ, Huang CC, Magee MF, Mete M, Montero AR, Nassar CM, Sack PA, Smith K, Youssef GA
|